Brent K Larson
Overview
Explore the profile of Brent K Larson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kozak M, Waters K, Larson B, Guindi M, Lai K, Hutchings D
Int J Surg Pathol
. 2025 Jan;
10668969241300965.
PMID: 39801174
. To determine the accuracy of grading pancreatic well-differentiated neuroendocrine tumors (PanNETs) on endoscopic ultrasound-guided fine needle biopsy (EUS-FNB). . Fifty-three (53) PanNETs from 52 patients with EUS-FNB and subsequent...
2.
Toussieng T, Larson B, Burch M, Gangi A, Gong J, Guindi M, et al.
Hum Pathol
. 2024 Nov;
154:105694.
PMID: 39580093
Aims: Metastatic tumors to the stomach can mimic primary gastric adenocarcinoma or be subtle and difficult to identify. The current study aimed to characterize the clinicopathology of metastases to the...
3.
McCloskey A, Waters K, Larson B, Guindi M, Lai K, Gaddam S, et al.
J Clin Pathol
. 2024 Oct;
PMID: 39461846
No abstract available.
4.
Ahmed M, Larson B, Osipov A, Azad N, Hendifar A
Oncotarget
. 2024 Oct;
15:741-747.
PMID: 39392392
Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related deaths, with adenosquamous carcinoma of the pancreas (ASCP), a rare variant, representing 1-10% of cases. Standard chemotherapy trials for pancreatic...
5.
Perrotta G, Mohamed G, Larson B, Osipov A, Ferrone C, Lo S, et al.
JAMA
. 2024 Sep;
332(13):1108-1110.
PMID: 39235802
No abstract available.
6.
Liang J, Rastegar R, Helou M, Mathur K, Larson B, Waters K, et al.
Am J Gastroenterol
. 2024 Sep;
PMID: 39225338
Introduction: Upper gastrointestinal (UGI) cancers, comprising malignancies of the esophagus, stomach, duodenum, pancreas, liver, biliary tract, and gallbladder, are the second leading cause of cancer-related mortality in the United States...
7.
Kozak M, Negrete D, Balzer B, Gaddam S, Guindi M, Hutchings D, et al.
Mod Pathol
. 2024 Jul;
37(10):100567.
PMID: 39025407
Several professional society guidelines suggest germline genetic testing for colorectal polyposis syndromes in patients with ≥10 lifetime adenomatous polyps. This study evaluated the factors associated with genetic testing decisions and...
8.
Chang C, Lee J, Waters K, Larson B
Dis Colon Rectum
. 2024 Jul;
67(10):1291-1303.
PMID: 38959470
Background: Checkpoint kinase 2 is a tumor suppressor gene in the DNA damage checkpoint system that may be mutated in several cancers. Patients with germline checkpoint kinase 2 mutations and...
9.
Delgado-Coka L, Roa-Pena L, Babu S, Horowitz M, Petricoin 3rd E, Matrisian L, et al.
Am J Clin Pathol
. 2024 Apr;
162(3):314-326.
PMID: 38642081
Objectives: To determine the role of keratin 17 (K17) as a predictive biomarker for response to chemotherapy by defining thresholds of K17 expression based on immunohistochemical tests that could be...
10.
Gonzalez-Mancera M, Siref A, Kosari K, Nissen N, Gaddam S, Hendifar A, et al.
Am J Clin Pathol
. 2024 Feb;
162(1):41-50.
PMID: 38345293
Objectives: Adenocarcinomas of the biliary tract frequently present diagnostic challenges because of their histologic overlap with benign and preinvasive lesions. The molecular profiles of biliary adenocarcinomas vary by anatomical location....